Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Is There an Acute Cardiac or Hepatic Involvement in Hospitalized Sickle Cell Disease Patients with a Vaso-Occlusive Crisis?

Steven Bennington, Christian Kassasseya, Mehdi Khellaf, Bertrand Godeau, France Pirenne, Anoosha Habibi, Christophe Duvoux, Stephane Moutereau, Pablo Bartolucci

Blood (2022) 140 (Supplement 1): 2541–2542.

https://doi.org/10.1182/blood-2022-169241

Published: 2022

Journal Articles

Validation of a Predictive Score of Acute Chest Syndrome (presev-2 study) in Adults

Christian Kassasseya, MD, Kene Sekou, MD, Tatiana Besse-Hammer, MD, Ruben Nzouakou, MD, Jean-Benoît Arlet, MD, Jean Magnang, MD, Louis Affo, MD, Sandrine Dautheville, MD, Stéphanie Ngo, MD, Mehdi Khellaf, MD PhD, Dapa Aly Diallo, MD PhD, Pablo Bartolucci, MD PhD

Blood (2020) 136 (Supplement 1): 23.

https://doi.org/10.1182/blood-2020-143035

Published: 2020

Journal Articles

Outcome of Severe Vaso Occlusive Crisis in Sickle Cell Disease Adults Admitted to Referral Centers in Africa and Europe. Preliminary Results from the Presev 2 Study

Dapa Diallo, Prof, Mehdi Khellaf, Gonzalo De Luna, Sandrine Dautheville, Louis Affo, Stephanie Ngo, MD, Tatiana besse-Hammer, Yvon Segbena, jean Benoit Arlet, François Lionnet, Sylvain le-Jeune, Anoosha Habibi, MD, Bertrand Godeau, Frédéric Galactéros, MDPhD, Pablo Bartolucci, MD PhD

Blood (2017) 130 (Supplement 1): 3529.

https://doi.org/10.1182/blood.V130.Suppl_1.3529.3529

Published: 2017

Journal Articles

Autologous 111 Indium-Oxinate-Labelled Platelet Sequestration Study in Patients with Immune Thrombocytopenia Treated By Thrombopoietic Receptor-Agonists

Blood (2016) 128 (22): 2555.

https://doi.org/10.1182/blood.V128.22.2555.2555

Published: 2016

Journal Articles

A Multi-Centre Randomized and Double-Blind Controlled Trial of Rituximab for Warm Autoimune Hemolytic Anemia in Adults

Marc Michel, MD, Louis Terriou, MD, Françoise Roudot-Thoraval, MD PhD, Mohamed Hamidou, MD PhD, Mikael Ebbo, MD, Guillaume Le guenno, Sylvain Audia, MD PhD, Bruno Royer, MD, anne-Sophie Morin, MD, Jean Marie Michot, MD, Arnaud Jaccard, MD PhD, Laurent Frenzel, MD PhD, Corinne Haioun, MD PhD, Mehdi Khellaf, MD, Bertrand Godeau, MD PhD

Blood (2015) 126 (23): 3338.

https://doi.org/10.1182/blood.V126.23.3338.3338

Published: 2015

Journal Articles

Long-Term Complications after Splenectomy in Adult Chronic Immune Thrombocytopenia with a Minimum Follow up of 10 Years. First Results from a Single-Center Case-Control Study in 140 Patients with Primary ITP

Lan-huong Thai, Matthieu Mahevas, MD PhD, Françoise roudot-Thoraval, Laetitia Languille, Guillaume Dumas, Mehdi Khellaf, Philippe Bierling, MD, Marc Michel, MD PhD, Bertrand Godeau, MDPhD

Blood (2014) 124 (21): 232.

https://doi.org/10.1182/blood.V124.21.232.232

Published: 2014

Journal Articles

Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients

Blood (2014) 124 (22): 3228–3236.

https://doi.org/10.1182/blood-2014-06-582346

Published: 2014

Journal Articles

Safety and Efficacy Of Rituximab In adult’s Immune Thrombocytopenia (ITP) : Results After One-Year Of Follow-Up In 252 Patients From The Prospective French ITP-Ritux Registry

Blood (2013) 122 (21): 450.

https://doi.org/10.1182/blood.V122.21.450.450

Published: 2013

Journal Articles

Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group

Blood (2013) 121 (14): 2596–2606.

https://doi.org/10.1182/blood-2012-07-442392

Published: 2013

Includes: Supplemental data

Journal Articles

A case-control study to assess the risk of immune thrombocytopenia associated with vaccines

Blood (2012) 120 (25): 4938–4944.

https://doi.org/10.1182/blood-2012-05-431098

Published: 2012

Includes: Supplemental data

Journal Articles

Switching From Romiplostim to Eltrombopag or Vice Versa for Immune Thrombocytopenia: Efficacy and Safety in 46 Patients

Mehdi Khellaf, Jean-François Viallard, MD, PhD, Mohamed Hamidou, Stephane Cheze, Francois Lefrere, Olivier Fain, Sylvain Audia, M.D., Ph.D., Fabrice Jardin, MD, PhD, Emmanuel Gyan, MD, PhD, jean Marc Durand, Corinne Haioun, Philippe Bierling, MD, Marc Michel, Bertrand Godeau, MD

Blood (2012) 120 (21): 4651.

https://doi.org/10.1182/blood.V120.21.4651.4651

Published: 2012

Journal Articles

A Monocentric, Prospective, Observational Study On Vaso-Occlusive Crisis (VOC) in Adult Sickle-Cell Disease (SCD).

Pablo Bartolucci, MD, PhD, Anoosha Habibi, Mehdi Khellaf, Anne sophie Lascaux, Aline Santin, Françoise Roudot Thoraval, Stéphane Moutereau, Hélène Jouault, Yves Levy, MD, PhD, Bertrand Renaud, Frederic Galacteros, MD PhD, Bertrand Godeau, MD

Blood (2012) 120 (21): 2115.

https://doi.org/10.1182/blood.V120.21.2115.2115

Published: 2012

Journal Articles

Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program

Blood (2011) 118 (16): 4338–4345.

https://doi.org/10.1182/blood-2011-03-340166

Published: 2011

Includes: Supplemental data

Journal Articles

Impact of Pregnancy On the Course of Immune Thrombocytopenic Purpura: An Observational Study On 44 Cases.

Lilia Baili, Mehdi Khellaf, Laetitia Languille, Philippe Bierling, MD, PhD, Bertrand Godeau, Marc Michel

Blood (2009) 114 (22): 1320.

https://doi.org/10.1182/blood.V114.22.1320.1320

Published: 2009

Journal Articles

Costs of Managing Chronic Immune Thrombocytopenic Purpura (ITP) in Adults: A Retrospective Analysis.

Mehdi Khellaf, Laurent Eckert, Priscille Poitrinal, Camille Francesconi, Albert Haddad, Laetitia Languille, Philippe Bierling, MD, PhD, Marc Michel, Lionel Riou França, Robert Launois, Bertrand Godeau

Blood (2009) 114 (22): 4462.

https://doi.org/10.1182/blood.V114.22.4462.4462

Published: 2009

Journal Articles

Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the “real-life” : Result of the French Experience in 72 Adults.

Blood (2009) 114 (22): 3519.

https://doi.org/10.1182/blood.V114.22.3519.3519

Published: 2009

Journal Articles

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study

Bertrand Godeau, Raphael Porcher, Olivier Fain, François Lefrère, Pierre Fenaux, Stéphane Cheze, Anne Vekhoff, Marie-Paule Chauveheid, Jerôme Stirnemann, Lionel Galicier, Emmanuelle Bourgeois, Stéphanie Haiat, Bruno Varet, Michel Leporrier, Thomas Papo, Mehdi Khellaf, Marc Michel, Philippe Bierling

Blood (2008) 112 (4): 999–1004.

https://doi.org/10.1182/blood-2008-01-131029

Published: 2008

Journal Articles

Prevalence and Clinical Significance of Elevated Antiphospholipid Antibodies in Adults with Immune Thrombocytopenic Purpura.

Carole Pierrot-Deseilligny, MD, Mehdi Khellaf, MD, Michele Gouault, MD, PhD, Liliane Intrator, MD, PhD, Marc Michel, MD, Philippe Bierling, MD, PhD, Bertrand Godeau, MD

Blood (2006) 108 (11): 1083.

https://doi.org/10.1182/blood.V108.11.1083.1083

Published: 2006

NARROW

Is There an Acute Cardiac or Hepatic Involvement in Hospitalized Sickle Cell Disease Patients with a Vaso-Occlusive Crisis?

Validation of a Predictive Score of Acute Chest Syndrome (presev-2 study) in Adults

Outcome of Severe Vaso Occlusive Crisis in Sickle Cell Disease Adults Admitted to Referral Centers in Africa and Europe. Preliminary Results from the Presev 2 Study

Autologous 111 Indium-Oxinate-Labelled Platelet Sequestration Study in Patients with Immune Thrombocytopenia Treated By Thrombopoietic Receptor-Agonists

A Multi-Centre Randomized and Double-Blind Controlled Trial of Rituximab for Warm Autoimune Hemolytic Anemia in Adults

Long-Term Complications after Splenectomy in Adult Chronic Immune Thrombocytopenia with a Minimum Follow up of 10 Years. First Results from a Single-Center Case-Control Study in 140 Patients with Primary ITP

Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients

Safety and Efficacy Of Rituximab In adult’s Immune Thrombocytopenia (ITP) : Results After One-Year Of Follow-Up In 252 Patients From The Prospective French ITP-Ritux Registry

Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group

A case-control study to assess the risk of immune thrombocytopenia associated with vaccines

Switching From Romiplostim to Eltrombopag or Vice Versa for Immune Thrombocytopenia: Efficacy and Safety in 46 Patients

A Monocentric, Prospective, Observational Study On Vaso-Occlusive Crisis (VOC) in Adult Sickle-Cell Disease (SCD).

Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program

Impact of Pregnancy On the Course of Immune Thrombocytopenic Purpura: An Observational Study On 44 Cases.

Costs of Managing Chronic Immune Thrombocytopenic Purpura (ITP) in Adults: A Retrospective Analysis.

Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the “real-life” : Result of the French Experience in 72 Adults.

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study

Prevalence and Clinical Significance of Elevated Antiphospholipid Antibodies in Adults with Immune Thrombocytopenic Purpura.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only